chrisvoncsefalvay/vaers-outcomes huggingface dataset:
headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) and CHILLS (chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced HEADACHE (headache) and CHILLS (chills). At the time of the report, HEADACHE (headache) and CHILLS (chills) outcome was unknown. Not Provided          Relevant concomitant medications were not reported.   Treatment information was not provided.    Reporter did not allow further contact
4 days after vaccine couldn't grasp with hands, numbness, tingle throughout arms and hands, loss of balance, now uses a walker, can not sit up alone. Had to have emergency surgery ACDF of C4/5 and C5/6
COVID arm in both arms; 11 days after first shot large lips, red, warm, and itchy; 11 days after first shot large lips, red, warm, and itchy; 11 days after first shot large lips, red, warm, and itchy; 11 days after first shot large lips, red, warm, and itchy; Has stinging in first arm a couple times a week/Second arm stings 3 times daily; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (COVID arm in both arms), LIP SWELLING (11 days after first shot large lips, red, warm, and itchy), LIP ERYTHEMA (11 days after first shot large lips, red, warm, and itchy), FEELING HOT (11 days after first shot large lips, red, warm, and itchy) and LIP PRURITUS (11 days after first shot large lips, red, warm, and itchy) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    In June 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced VACCINATION SITE REACTION (COVID arm in both arms), LIP SWELLING (11 days after first shot large lips, red, warm, and itchy), LIP ERYTHEMA (11 days after first shot large lips, red, warm, and itchy), FEELING HOT (11 days after first shot large lips, red, warm, and itchy), LIP PRURITUS (11 days after first shot large lips, red, warm, and itchy) and LIMB DISCOMFORT (Has stinging in first arm a couple times a week/Second arm stings 3 times daily). At the time of the report, VACCINATION SITE REACTION (COVID arm in both arms), LIP SWELLING (11 days after first shot large lips, red, warm, and itchy), LIP ERYTHEMA (11 days after first shot large lips, red, warm, and itchy), FEELING HOT (11 days after first shot large lips, red, warm, and itchy) and LIP PRURITUS (11 days after first shot large lips, red, warm, and itchy) had resolved and LIMB DISCOMFORT (Has stinging in first arm a couple times a week/Second arm stings 3 times daily) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medication was provided. No treatment medication was provided.  The patient had received first shot of the vaccine 9 months ago. While reading FAQ L.3 (Clinical Trial side effects), the patient reported that the patient had most side effects all of those except for the nausea.  The patient had stinging in first arm a couple times in a week and rubbing it lightly makes it go away.  The patient's second arm stings 3 times daily. The patient rubs it lightly and it goes away. The patient felt like being stung by a mosquito and felt irritating. The stinging was less in first arm.   This case was linked to MOD-2022-512094 (Patient Link).
Soreness in arm for 10 days; Heaviness and shortness and breathing; Cough; This is a spontaneous report from a contactable consumer (patient). A elderly male (Age:68; Unit: Unknown) patient received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 06Apr2021 12:00 as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. Medical history included covid-19 from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 06Apr2021 03:00 the patient experienced soreness in arm for 10 day, heaviness and shortness and breathing, cough. Outcome of Event was Not recovered.  No follow-up attempts are possible. Information about Lot/Batch number cannot be obtained.
Within 2 months after receiving the 2nd shot, patient developed extremely high pressure in the left eye, glaucoma, and irreparable damage to a quarter of the eye with degraded vision. Pressure slightly high in the right eye as well. Patient had eyes checked 4 months prior to the injection and per the ophthalmologist patients eyes were fine. Brain scans and MRI all normal. Patient has seen several specialists who were surprised by the unusual and aggressive progression of the eye.  Also of note, patient had spasm on right side of face for 10 years possibly due to a blood vessel wrapped around a facial nerve due to trauma that was treated with botox. He has had occasional spasms after stopping the botox 1-2years ago, but the spasms have started back up again with a vengeance within 1 week of the injection.
Bells Palsey 02May2021 Low grade fever and fatigue 12May2021 Breathing issues started 14May2021 Covid 19 Positive Test 15May2021  Covid related pneumonia 19May21 Hospital admitted 19May2021 to 24May2021 Tingling in fingers and toes started 30Jun2021 to present.
Severe swelling, inflammation, hardness and warmth to arm at injection site and surrounding tissue up to a 10 cm circumference. Painful and itching, requiring medical treatment within 24 hours.
Sore arm; 103 degrees fever/Fever; Body aches; Tiredness; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Sore arm), PYREXIA (103 degrees fever/Fever), MYALGIA (Body aches) and FATIGUE (Tiredness) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013421A, 020B21A and 051F21A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm), PYREXIA (103 degrees fever/Fever), MYALGIA (Body aches) and FATIGUE (Tiredness). At the time of the report, PAIN IN EXTREMITY (Sore arm), PYREXIA (103 degrees fever/Fever), MYALGIA (Body aches) and FATIGUE (Tiredness) had resolved.     DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 103 degree fever. No concomitant drug information was provided. It was reported that the patient had experienced  mild to moderately severe reactions after the Moderna vaccination. Experienced 103 degree fever with the 2nd dose. The adverse reactions experienced by the patient had lasted for approximately 2 days and there were no additional problems. Patient didn't ever had COVID-19 positive test or diagnosis previously. No treatment drug information was provided. Most recent FOLLOW-UP information incorporated above includes: On 24-Aug-2022: Follow-up received and updated vaccination dates and lot numbers.
Email to COVID CARE - referred to PCP "I'm having side effects after the second shot. I'm having vomiting, diarrhea, can barely talk, balance problems, dizziness, and back pain. I'm very tired. I had a brain bleed six years ago."
Received flu shot 10/25/04 in am. 10/26/04 am went to a previously scheduled Dr visit Dr suggested she try Flaxseed-to reduce cholesterol. Tried Flaxseed on 10/26/04 for dinner. 10/27/04 awoke with hives, redness, itching on face and neck. Follow up with private physician 10/27/04 regarding symptoms. Dr put her on Zyrtec daily for 10 days. Began taking Zyrtec immediately. As of 11/1/04 symptoms decreased but continued. 11/3/04 follow up call finds client with continued redness of face and swelling of neck and prickling feeling in throat and neck area. Plans to follow up with own Dr or specialist. 11/29/04 was received by Dr on 11/2/04 recommended f/u TC which was done. Also recommended client f/u with PP re symptoms if continued. See above client plans to do same. Report mailed.
3/30/21: Patient presented and was admitted for abnormal labs, nausea and dry heaving x 1 week. On admission, patient was found to be hypokalemic (K 2.2), creatinine of 4.81. Patient received second dose of COVID vaccine this morning.  Patient was tested positive for Covid-19 at this visit.   Per the EUA, hospitalizations to be reported irrespective of attribution to vaccine.
Fever of 102.5 began around one-one & a half hours after receiving DTaP, HIB and Prevnar (PVC) ("vaccines").  Within the second hour, the fever spiked to 103.7 and stayed between 103.5-104 for approximately 24 hours.  Fever would not reduce with Tylenol or Motrin.  Fever went down for approximately 6-8 hours between 24-36 hours, then reappeared at 103.9 around 36 hours and remained for approximately 8-12 hours.  Fever-lowering medications were given again, but did not significnatly reduce fever.  Additionally, my son has large, red, swollen welts on his legs at the injection site.  They are larger than a quarter and very red; they were quite swollen and sore for approximately 48 hours.  The welts are still very visible (4 days after vaccines administered).  Photos available if necessary.
Pt given expired vaccine. Moderna contacted and recommended to repeat dose. Patient contacted and asked to return to clinic
I received first shot on 12/30/2020 and second shot on 01/28/2021. I started to loose weight from late January 2021, fatigue and muscle weakness. I had a routine appointment on 7/16/2021 and labs were drawn. My labs showed TSH of 0.1 and T4 of 2.7 and I was diagnosed with hyperthyroidism. After diagnosis, I was started on Methimazole 10mg daily and Propranolol 20mg TID which was later increased to 40mg TID. During the course of treatment I had USG of thyroid done which showed increased blood supply in thyroid gland with -ve TPO Ab and -ve TSI. Later, I had thyroid uptake which showed 24hr thyroid RAIU of 1.3% and I was diagnosed with silent thyroiditis. At this time, my Methimazole has been stopped and Propranolol has been changed to PRN basis with monthly TSH test.  I have no history of side effects from vaccines, allergic reaction to medication, history of thyroid issues and there is no family history of thyroid issues.
Pt had redness about 2" diameter 2" from injection site started on antibiotic from doctor.
2 hours after injection, started to wheeze with some breathing difficulty, used albuterol inhaler (1 puff), next day- had red rash about size of golf ball was hot and puffy
Swelling left thigh 5" x 5' redness (+) minimal pain (+) Swelling (+)
Sudden high blood pressure right after shot, followed by shaking, fever, and stomach ache. All symptoms where right after the vaccine at the location given. 911 was called and was told he had a reaction and blood pressure was high. Hypertension, and shaking lasted for a few minutes.. fever went away in couple hours. Stomach ache lasted couple days.. Was told by medics to see medical personnel for check up. Has appointment with medical doctor for 3/8/2021.
fatigue, fever, sore throat, abdominal pain, nausea, vomiting, dizziness
Headache, Sedation, Arthralgia, NauseaVomiting, chills Narrative:  Other Relevant History:
Pt reported that the left side of her brain became blocked sometime after receiving Flu vaccine, no exact date given pt would not reveal MD name but MRI and Cat Scan were normal. PT recovered threw the us of every work.
chills, headache, body ache, (denies any fever)- ongoing Adv that symptoms are completely normal and should resolve in a few days, can use the following for symptomatic relief: APAP, IBU (pt also has naproxen adv not to mix with IBU); warm beverages, keep hydrated, heating pads. Adv to call back: if symptoms worsen. PCC will FU tomorrow.
Received flu vaccine on 10/27/09 at a flu vaccine clinic done by the Hospital. Fever started on 10/29/09 around 5am. Maximum elevation was 104.1.
red non raised rash face, neck, bilateral forearms, hands; red non raised rash face, neck, bilateral forearms, hands; This is a spontaneous report from a contactable nurse (patient) reported for herself. A 56-years-old female patient (patient was not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: ER8732, Expiration date: unknown) intramuscular, administered in left arm on 22Apr2021 (age at vaccination was 56 years) as dose 1, single for COVID-19 immunization. The patient's medical history included factor 5 liedham and minimal change nephrotic syndrome as a kid. The patient did not have any known allergies. The patient did not receive any concomitant medications or other medications in two weeks of vaccination. The facility where the most recent COVID-19 vaccine was administered was Other. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient had reaction to Pfizer COVID-19 injection. On 22Apr2021, within 2 hours, the patient experienced red non-raised rash face, neck, bilateral forearms, hands. The patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EW0153, Expiration date: unknown) intramuscular, administered in left arm on 18May2021 at 17:30 pm (age at vaccination was 56 years) as dose 2, single for COVID-19 immunization. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
at ER patient was diagnosed with a stroke and now remains hospitalized; fever; bodyache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CEREBROVASCULAR ACCIDENT (at ER patient was diagnosed with a stroke and now remains hospitalized) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037B21A and 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Apr-2021, the patient experienced PYREXIA (fever) and MYALGIA (bodyache). On 27-Apr-2021, the patient experienced CEREBROVASCULAR ACCIDENT (at ER patient was diagnosed with a stroke and now remains hospitalized) (seriousness criteria hospitalization and medically significant). On 18-Apr-2021, PYREXIA (fever) and MYALGIA (bodyache) had resolved. At the time of the report, CEREBROVASCULAR ACCIDENT (at ER patient was diagnosed with a stroke and now remains hospitalized) had not resolved. Not Provided          No concomitant medication was provided.  Treatment included hospitalization.  The patient received both scheduled doses of mRNA-1273 prior to the event; therefore, action taken with the drug in response to the event is not applicable.  Company Comment - Based on the information provided which includes a strong temporal association between the use of mRNA-1273 vaccine and onset of the reported events, a causal relationship cannot be excluded. Fever and myalgia are consistent with the product safety profile.; Sender's Comments: Based on the information provided which includes a strong temporal association between the use of mRNA-1273 vaccine and onset of the reported events, a causal relationship cannot be excluded. Fever and myalgia are consistent with the product safety profile.
Oily face skin; Acne; Mild pain at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of SEBORRHOEA (Oily face skin), ACNE (Acne) and INJECTION SITE PAIN (Mild pain at the site of injection) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetic neuropathy. Concomitant products included VITAMIN D NOS for Supplementation therapy, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) and PARACETAMOL (TYLENOL) for an unknown indication.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced SEBORRHOEA (Oily face skin), ACNE (Acne) and INJECTION SITE PAIN (Mild pain at the site of injection). At the time of the report, SEBORRHOEA (Oily face skin), ACNE (Acne) and INJECTION SITE PAIN (Mild pain at the site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment provided.
BODY ACHE; SHAKING; FEELING HOT AND THEN COLD; TROUBLED SLEEPING; NOT FEELING HUNGRY; SEVERE HEADACHE; FEELING VERY TIRED; MUSCLE ACHES (WHOLE BODY IN GENERAL ACHES); This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: not reported) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced body ache. On APR-2021, the subject experienced shaking. On APR-2021, the subject experienced feeling hot and then cold. On APR-2021, the subject experienced troubled sleeping. On APR-2021, the subject experienced not feeling hungry. On APR-2021, the subject experienced severe headache. On APR-2021, the subject experienced feeling very tired. On APR-2021, the subject experienced muscle aches (whole body in general aches). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the severe headache, feeling very tired, muscle aches (whole body in general aches), body ache, shaking, feeling hot and then cold, troubled sleeping and not feeling hungry was not reported. This report was non-serious.
This spontaneous report was received from a doctor of pharmacy refers to a patient of unknown age who on 05-NOV-2012, was vaccinated with a dose of PNEUMOVAX23 (lot number 667695/1028Z) (route and dose not reported) that was expired. The vaccine expired on 28-JAN-2012. No adverse symptoms were reported. Additional information has been requested.
Swelling, warmth at injection site, gradually increasing in 1st 48 hrs after IZ given.
Abnomal Pap screening after first 2 injections. Biopsy done and diagnosed as cervical dysplasia. Had all abnormal cells removed, then had normal pap screening afterwards.
20 minutes after injection inner ear pressure, light headedness, dizziness, faintness. Three hours after injection low grade fever, dizziness, fatigue. 24+ hours after injection headache, fever, arm soreness, inner ear pressure, hot flashes, neck tension, eye "floaters"
Redness and blotchy spots at site of injection. Hives, and blotchy spots on the neck area. Looking flushed, and sweaty. Complaint of intense itching. Headache.
This spontaneous case was initially received on 03-Dec-2015. The case report was received from a Health Professional and concerns an adult female patient. Weight: not provided, Height: not provided. Linked Case ID: US-BEH-2016058107 (Same patient, 2013 episode) and US-BEH-2015055519 (Same patient, 2015 episode). In 2013, the patient received a flu shot and experienced fever, chills, headaches and joint pain. For concomitant medication and therapy dates refer to the appropriate report sections. On an unspecified date in 2014, the patient received AFLURIA on unknown dates, Batch no: not provided, Route of administration: not provided, Dose: Administered in 2014. No additional drugs suspected. On an unknown date, after starting treatment with AFLURIA the patient experienced Joint pain, Fever, Chills, Headaches. For relevant test results see appropriate report section.
Hot Area; Red Area; Raised Area; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot Area), VACCINATION SITE ERYTHEMA (Red Area) and VACCINATION SITE INDURATION (Raised Area) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Dementia.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Hot Area), VACCINATION SITE ERYTHEMA (Red Area) and VACCINATION SITE INDURATION (Raised Area). At the time of the report, VACCINATION SITE WARMTH (Hot Area), VACCINATION SITE ERYTHEMA (Red Area) and VACCINATION SITE INDURATION (Raised Area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. treatment included- Cold Pack
almost killed me; 3 days without be able to get off the bed; without be able to move my limbs; Initial information received on 23-Oct-2021 regarding an unsolicited valid non-serious case received from a consumer or non-healthcare professional via.  This case involves a patient (unknown demographic) who had almost killed me (unevaluable event), 3 days without be able to get off the bed (bedridden) and without be able to move my limbs (limb immobilisation) after receiving INFLUENZA VACCINE.  It was unknown if the patient had any medical history, concomitant disease or risk factor.   The patient past medical treatment, vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number and expiry date not reported] via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious almost killed me (unevaluable event),without be able to move my limbs (limb immobilization) (unknown latency) and 3 days without be able to get off the bed (bedridden) (3 day latency) following the administration of INFLUENZA VACCINE.  It was reported "Last one almost killed me, 3 days without be able to get off the bed or move my limbs. never again."  Laboratory details were not reported.  It was not reported if the patient received a corrective treatment for the events.  At time of reporting, the outcome was unknown for the reported events.  There will be no information available on the batch number for this case.
Pt recvd vax 11AM 15JAN92 & started a high pitch scream x 2 hrs would not settle down or nurse-fussy; woke up 130AM t103 APAP given; mom state pt appears fine but does have a cough this AM-others in home w/cold;
Low level flu like feelings-5 days. Persistent headache for 7 days. Blurred vision-7 days.